Section Arrow
Quote
MPLT.NASDAQ
- MapLight Therapeutics Inc.
Quotes are at least 15-min delayed:2026/03/02 21:20 EST
Regular Hours
Last
 17.6
+0.33 (+1.91%)
Day High 
18 
Prev. Close
17.27 
1-M High
20.42 
Volume 
101.20K 
Bid
17.54
Ask
17.6
Day Low
16.5901 
Open
17.27 
1-M Low
15.48 
Market Cap 
783.59M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 17.62 
20-SMA 17.44 
50-SMA 17.88 
52-W High 21.55 
52-W Low 12.24 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.48/--
Enterprise Value
789.39M
Balance Sheet
Book Value Per Share
-6.04
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
IBRXImmunityBio10.44+0.64+6.53%-- 
QNCXQuince Therapeutics0.0988-0.0213-17.74%-- 
OCULOcular Therapeutix10.98+2.035+22.75%-- 
QUREuniQure NV10.5-5.08-32.61%-- 
GERNGeron Corp1.55-0.13-7.74%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.